JSPR - Latest News

Jasper Therapeutics, Inc. (JSPR), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $12.8M. Beta to the broader market is 3.03.

The article list below shows the most recent JSPR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent JSPR Headlines

Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

globenewswire.com - Aug 14, 2026

Acquisition of Kira Pharmaceuticals closed in July creating a combined company with a robust portfolio of clinical stage assets focused on immunologic

Jasper Closes Kira Deal, Extends Cash Runway

benzinga.com - Jul 17, 2026

Jasper Therapeutics Inc. (NASDAQ:JSPR) on Thursday said it completed its all-stock acquisition of Kira Pharmaceuticals, bringing the two biotechnolog

Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

globenewswire.com - Jul 16, 2026

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven diso

Bears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now

zacks.com - Jun 3, 2026

Jasper Therapeutics (JSPR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

globenewswire.com - Jun 1, 2026

REDWOOD CITY, Calif. , June 01, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc.

How News Affects JSPR Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track JSPR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked JSPR news questions

What is the latest JSPR news headline?

The most recent JSPR headline (Aug 14, 2026) is "Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the JSPR news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What JSPR news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual JSPR options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.